Show Notes:
At just seven months old, Phil Southerland was diagnosed with type-1 diabetes. At the time, this was the youngest recorded case of diabetes and his parents were told he’d be dead or blind by 2025.
Fast forward to today: He is the Founder and CEO of Supersapiens—a continuous glucose monitoring platform built to optimize glucose regulation for performance. After seeing the power of constant glucose visibility in his own athletic pursuits, Phil transformed his personal challenges into a global solution.
He’s spent the last few years pioneering glucose monitoring technology for athletes, along the way breaking misconceptions and stigma about glucose, diabetes, and performance through data. His latest venture—Supersapiens Diabetes— brings the Supersapiens platform to the diabetes population in the U.S.
Today’s episode covers glucose as a proxy for health and performance, using sport as a platform for inspiration and change, and how the narrative around glucose monitoring has evolved.
Timestamps:
[1:25]: Supersapiens and continuous glucose monitoring
[3:44]: How the narrative around glucose has evolved
[11:09]: Sports as a platform for change
[21:29]: Launching Supersapiens Diabetes in the US
[31:14]: 10-year outlook
Resources:
Republic (Crowd Funding Campaign)
Association between pre-exercise food ingestion timing and reactive hypoglycemia: Insights from a large database of continuous glucose monitoring data (European Journal of Sport Science)
Ep. 17: Phil Southerland, Founder and CEO of Supersapiens, on Unlocking Human Performance Through Glucose Regulation